Skip to content

Phadia Prime System

by Phadia AB

510(k) K151029Ref 12-4101-00

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None ongoing

1 closed

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), GUDID, synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number7333066BUDI0016LV Basic UDI-DI 07333066015101UDI-DIDate25 Mar 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number07333066015101 UDI-DI Date14 Oct 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Special NumberK151029 Date19 Jan 2016ClearedStatusActive

Official records

From the FDA record

Received by the FDA
17 Apr 2015
FDA decision
19 Jan 2016 (Substantially Equivalent)
FDA review time
277 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K151029 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

FDA GUDID

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 7333066BUDI0016LV registered 25 Mar 2026 Active
  • FDA 510(k) K151029 decided 19 Jan 2016 Active
  • FDA GUDID UDI-DI 07333066015101 listed 14 Oct 2016 Listed

Recalls

1 recall · FDA

    • Terminated Z-1276-2018 FDA Class II initiated 20 Nov 2017

    We want to inform all Phadia 250 system operators performing EliA Assays not to use the function OK to All in any version of Phadia Prime, up to and including 2.1.4, when rejecting and retesting samples with any EliA assay (the OK function may be used for rejecting single tests and dilution of samples in accordance with product DfU).

Timeline

4 dated events

  1. Cleared FDA 510(k) K151029
  2. Listed FDA GUDID 07333066015101
  3. Recall initiated FDA recalls Z-1276-2018
  4. Registered EUDAMED 7333066BUDI0016LV

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k) · GUDID

Full name
Phadia Prime
Generic name
Laboratory instrument/analyser application software IVD
Model / Ref / Catalog
12-4101-00
Primary DI / UDI-DI
07333066015101
Basic UDI-DI
7333066BUDI0016LV
510(k) Number
FDA product code
DHB
EMDN code
W0201020192 Automated immunochemistry analysers - IVD medical device software
GMDN term
Laboratory instrument/analyser application software IVD
Device class
Class A EUDAMED
Class II 510(k)GUDID
Regulation
21 CFR Part 866.5750
Special device type
Software
EU registration type
Standard device
EU market of registration
Sweden
Advisory committee
Immunology
FDA decision
SESE Substantially Equivalent
GUDID distribution status
In Commercial Distribution

Truth per registry

3 sources · 1 field differs

FieldEUDAMED510(k)GUDID
Device classEUDAMED
Class A
510(k)
Class II
GUDID
Class II

Device class is stated on each registry's own scale: Class A in the EU (EUDAMED), Class II in the US (FDA 510(k), FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Phadia Prime System is an in vitro diagnostic device classified as a Radioallergosorbent Test (RAST) Immunological System. It is designed for the quantitative measurement of specific IgE antibodies in human serum or plasma, enabling the diagnosis and monitoring of allergic conditions such as asthma, hay fever, and food allergies.

This system is supplied as a reagent kit for laboratory use and is intended for single-use only. It operates under in vitro diagnostic regulations, including FDA 510(k) clearance and IVDR compliance, with a classification as a Class II device. The system requires proper storage at controlled temperatures and adherence to manufacturer instructions for handling and disposal to ensure accuracy and reliability.

Devices cleared under K151029

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K151029
UDI-DISize and differences
Phadia Prime 12-4101-00
Phadia AB
12-4101-00 / 12-4101-0007333066015101 —On the market

Similar devices in this category

Other devices filed under AUTOMATED IMMUNOCHEMISTRY ANALYSERS - IVD MEDICAL DEVICE SOFTWARE.

Other devices from Phadia AB

See all devices from Phadia AB →

Properties

  • Professional testing
  • Prescription use
  • Lot / batch number
Other properties (23, all answered No)